L

Latchbio

latch.bio link_icon

Company Market Research Report: LatchBio



1. Company Overview


  • Name: LatchBio

  • Mission: LatchBio is centered around providing a modern data and computing solution for biotech R&D to make data analysis faster, cheaper, and more accessible, enabling biotechs to instantly accelerate their R&D milestones.

  • Founded By: No information is available

  • Headquarters: No information is available

  • Number of Employees: No information is available

  • Revenue: No information is available

  • Key People:

  • Alfredo Andere: Co-founder and CEO

  • Kenny Workman: Co-founder and CTO

  • Kyle Giffin: Co-founder and COO

  • Known For: LatchBio is known for its data platform that bridges teams of scientists and engineers with powerful computational resources to drive biotech research and development.


2. Products and Key Features


  • Overview: LatchBio offers products tailored for accelerating drug development, integrating lab teams and data, and enabling seamless collaboration in R&D environments.

  • Products:

  • Latch Data:

  • Description: Unlimited data storage, integrating instruments and data sources into a unified workspace.

  • Features: Unlimited storage; fine-grained user permissions; enterprise data security; integration with different data sources like AWS, GCP, etc.


  • Latch Registry:

  • Description: Harmonized database for metadata management.

  • Features: Spreadsheet-like interface for metadata; search and filter functionality; Python API for CRUD operations; connects with Latch Data.


  • Latch Workflow Manager:

  • Description: Orchestration platform for scalable bioinformatics workflows.

  • Features: Supports Nextflow based workflows; user-friendly no-code interface; auto-generation of workflow interfaces; scalable resource specification.


  • Latch Pods:

  • Description: Scalable, on-demand cloud computing resources.

  • Features: Instant setup of large cloud computers; Jupyter and RStudio support; reproducible environment management; auto-shutoff to control costs.


3. Recent Developments


  • New Product Launches: No information is available

  • New Features:

  • Enhanced integration for reproducibility and data security, ensuring compliance with SOC-2 Type II and HIPAA.

  • Introduced Pods for scalable, cloud-based computational power.

  • Partnerships: Collaborated with notable investors and leaders like George Church, Jeff Dean, and Laura Deming. Specific partnership details were not disclosed.


4. Additional Insights


  • Customer Base:

  • LatchBio is trusted by over 2000 scientists across 50+ biotech organizations.

  • The platform is highly valued for connecting bench scientists, computational scientists, and IT teams.


  • Impact and Feedback:

  • Customers have noted a significant reduction in analysis costs by utilizing LatchBio's infrastructure, with examples like RNAseq cost reduction from $2,000 to $150 per analysis.


5. Conclusion


This report provides an in-depth overview of LatchBio's market position as an enabler for biopharma R&D through its innovative data platform solutions. Through advanced integrations and scalable computing capabilities, LatchBio empowers biotech organizations to accelerate their research and development processes efficiently.



Note: The information regarding the company's founding date, number of employees, revenue, recent product launches, and specific new partnerships was not available in the provided data.